Overview

Self Selection Trial of Naproxen Sodium

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.

Phase:

Phase 3

Details

Lead Sponsor:

Bayer

Treatments:

Naproxen